{"title":"甲状腺功能障碍视神经病变的诊断和治疗。","authors":"Yasuhiro Takahashi, Aric Vaidya","doi":"10.1097/IIO.0000000000000452","DOIUrl":null,"url":null,"abstract":"Dysthyroid optic neuropathy (DON) is the most serious manifestation of thyroid eye disease (TED). According to the EUGOGO clinical guidelines, DON is classified as “sight-threatening” TED.1 The incidence of DON ranges from 4% to 8% in all cases of TED.2 Permanent and irreversible vision loss develops in 30% of cases without treatment,3 whereas vision can be rescued after prompt diagnosis and accurate management in most cases. This paper reviews the diagnosis and management of DON.","PeriodicalId":14338,"journal":{"name":"International Ophthalmology Clinics","volume":"63 3","pages":"233-248"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diagnosis and Management of Dysthyroid Optic Neuropathy.\",\"authors\":\"Yasuhiro Takahashi, Aric Vaidya\",\"doi\":\"10.1097/IIO.0000000000000452\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dysthyroid optic neuropathy (DON) is the most serious manifestation of thyroid eye disease (TED). According to the EUGOGO clinical guidelines, DON is classified as “sight-threatening” TED.1 The incidence of DON ranges from 4% to 8% in all cases of TED.2 Permanent and irreversible vision loss develops in 30% of cases without treatment,3 whereas vision can be rescued after prompt diagnosis and accurate management in most cases. This paper reviews the diagnosis and management of DON.\",\"PeriodicalId\":14338,\"journal\":{\"name\":\"International Ophthalmology Clinics\",\"volume\":\"63 3\",\"pages\":\"233-248\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Ophthalmology Clinics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/IIO.0000000000000452\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Ophthalmology Clinics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/IIO.0000000000000452","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Diagnosis and Management of Dysthyroid Optic Neuropathy.
Dysthyroid optic neuropathy (DON) is the most serious manifestation of thyroid eye disease (TED). According to the EUGOGO clinical guidelines, DON is classified as “sight-threatening” TED.1 The incidence of DON ranges from 4% to 8% in all cases of TED.2 Permanent and irreversible vision loss develops in 30% of cases without treatment,3 whereas vision can be rescued after prompt diagnosis and accurate management in most cases. This paper reviews the diagnosis and management of DON.
期刊介绍:
International Ophthalmology Clinics is a valuable resource for any medical professional seeking to stay informed and up-to-date regarding developments in this dynamic specialty. Each issue of this quarterly publication presents a comprehensive review of a single topic in a new or changing area of ophthalmology. The timely, tightly focused review articles found in this publication give ophthalmologists the opportunity to benefit from the knowledge of leading experts in this rapidly changing field.